Raymond Bergan

Professor

  • 3725 Citations
  • 35 h-Index
1977 …2020
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1991 2019

  • 3725 Citations
  • 35 h-Index
  • 96 Article
  • 2 Review article
2019

Genistein treatment duration effects biomarkers of cell motility in human prostate

Zhang, H., Gordon, R., Li, W., Yang, X., Pattanayak, A., Fowler, G., Zhang, L., Catalona, W. J., Ding, Y., Xu, L., Huang, X., Jovanovic, B., Kelly, D. L., Jiang, H. & Bergan, R., Mar 1 2019, In : PloS one. 14, 3, e0214078.

Research output: Contribution to journalArticle

Open Access
Genistein
genistein
Biomarkers
cell movement
Cell Movement

Involvement of the PI3K/Akt/Nrf2 Signaling Pathway in Resveratrol-Mediated Reversal of Drug Resistance in HL-60/ADR Cells

Li, Y., Guo, Y., Feng, Z., Bergan, R., Li, B., Qin, Y., Zhao, L., Zhang, Z. & Shi, M., Jan 1 2019, In : Nutrition and Cancer.

Research output: Contribution to journalArticle

Phosphatidylinositol 3-Kinases
Drug Resistance
Doxorubicin
Cell Line
HL-60 Cells

Synthesis and Biological Evaluation of 3-Arylindazoles as Selective MEK4 Inhibitors

Deibler, K. K., Schiltz, G. E., Clutter, M. R., Mishra, R. K., Vagadia, P. P., O'Connor, M., George, M. D., Gordon, R., Fowler, G., Bergan, R. & Scheidt, K. A., Jan 1 2019, In : ChemMedChem.

Research output: Contribution to journalArticle

MAP Kinase Kinase 4
Benzoic Acid
Molecular modeling
Oncology
p38 Mitogen-Activated Protein Kinases

Whole-body imaging of cell death provides a systemic, minimally invasive, dynamic, and near-real time indicator for chemotherapeutic drug toxicity

Johnson, S. E., Ugolkov, A., Haney, C. R., Bondarenko, G., Li, L., Waters, E. A., Bergan, R., Tran, A., O'Halloran, T. V., Mazar, A. & Zhao, M., Feb 15 2019, In : Clinical Cancer Research. 25, 4, p. 1331-1342 12 p.

Research output: Contribution to journalArticle

Whole Body Imaging
Drug-Related Side Effects and Adverse Reactions
Cell Death
Drug Therapy
Toxicology
2018
2 Citations (Scopus)

DNA repair gene alterations and PARP inhibitor response in patients with metastatic castration-resistant prostate cancer

Lu, E., Thomas, G., Chen, Y., Wyatt, A. W., Lloyd, P., Youngren, J., Quigley, D., Bergan, R., Bailey, S., Beer, T. T., Feng, F. Y., Small, E. J. & Alumkal, J., Aug 1 2018, In : JNCCN Journal of the National Comprehensive Cancer Network. 16, 8, p. 933-937 5 p.

Research output: Contribution to journalArticle

Castration
DNA Repair
Prostatic Neoplasms
Genes
BRCA2 Gene
Oncology
Biopsy
Genes
Tumors
Testing
4 Citations (Scopus)

Precision therapeutic targeting of human cancer cell motility

Xu, L., Gordon, R., Farmer, R., Pattanayak, A., Binkowski, A., Huang, X., Avram, M., Krishna, S., Voll, E., Pavese, J., Chavez, J., Bruce, J., Mazar, A., Nibbs, A., Anderson, W., Li, L., Jovanovic, B., Pruell, S., Valsecchi, M., Francia, G. & 3 others, Betori, R., Scheidt, K. & Bergan, R., Dec 1 2018, In : Nature Communications. 9, 1, 2454.

Research output: Contribution to journalArticle

locomotion
Cell Movement
Toxicity
Assays
Carrier Proteins

Prevention of colonic neoplasia with polyethylene glycol: A short term randomized placebo-controlled double-blinded trial

Wali, R. K., Bianchi, L., Kupfer, S., De La Cruz, M., Jovanovic, B., Weber, C., Goldberg, M. J., Rodriguez, L. M., Bergan, R., Rubin, D., Tull, M. B., Richmond, E., Parker, B., Khan, S. & Roy, H. K., Apr 1 2018, In : PLoS One. 13, 4, e0193544.

Research output: Contribution to journalArticle

polyethylene glycol
placebos
Placebos
neoplasms
Neoplasms
2 Citations (Scopus)

The Role of Cruciferous Vegetables and Isothiocyanates for Lung Cancer Prevention: Current Status, Challenges, and Future Research Directions

Zhang, Z., Bergan, R., Shannon, J. J., Slatore, C. G., Bobe, G. & Takata, Y., Sep 1 2018, In : Molecular Nutrition and Food Research. 62, 18, 1700936.

Research output: Contribution to journalReview article

Isothiocyanates
isothiocyanates
lung neoplasms
Vegetables
Lung Neoplasms
2017
2 Citations (Scopus)

A Chemical Probe Strategy for Interrogating Inhibitor Selectivity Across the MEK Kinase Family

Deibler, K. K., Mishra, R. K., Clutter, M. R., Antanasijevic, A., Bergan, R., Caffrey, M. & Scheidt, K. A., May 19 2017, In : ACS Chemical Biology. 12, 5, p. 1245-1256 12 p.

Research output: Contribution to journalArticle

MAP Kinase Kinase Kinases
Mitogen-Activated Protein Kinase Kinases
Phosphotransferases
Oncology
p38 Mitogen-Activated Protein Kinases
7 Citations (Scopus)

A way forward for cancer chemoprevention: Think local

Rabadi, L. A. & Bergan, R., Jan 1 2017, In : Cancer Prevention Research. 10, 1, p. 14-35 22 p.

Research output: Contribution to journalReview article

Chemoprevention
Neoplasms
Carcinogenesis
Therapeutics
Organs at Risk
4 Citations (Scopus)

Selenomethionine and methyl selenocysteine: Multiple-dose pharmacokinetics in selenium-replete men

Marshall, J. R., Burk, R. F., Ondracek, R. P., Hill, K. E., Perloff, M., Davis, W., Pili, R., George, S. & Bergan, R., 2017, In : Oncotarget. 8, 16, p. 26312-26322 11 p.

Research output: Contribution to journalArticle

Selenomethionine
Selenium
Pharmacokinetics
Neoplasms
Yeasts
2016
141 Citations (Scopus)

Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancer

Graff, J., Alumkal, J., Drake, C. G., Thomas, G., Redmond, W. L., Farhad, M., Cetnar, J., Ey, F. F., Bergan, R., Slottke, R. & Beer, T. T., Aug 1 2016, In : Oncotarget. 7, 33, p. 52810-52817 8 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Cell Death
Castration
Hypothyroidism
Biopsy
2015
35 Citations (Scopus)

Blood Telomere Length Attrition and Cancer Development in the Normative Aging Study Cohort

Hou, L., Joyce, B. T., Gao, T., Liu, L., Zheng, Y., Penedo, F. J., Liu, S., Zhang, W., Bergan, R., Dai, Q., Vokonas, P., Hoxha, M., Schwartz, J. & Baccarelli, A., Jun 1 2015, In : EBioMedicine. 2, 6, p. 591-596 6 p.

Research output: Contribution to journalArticle

Telomere
Blood
Cohort Studies
Aging of materials
Neoplasms
29 Citations (Scopus)

Genistein suppresses FLT4 and inhibits human colorectal cancer metastasis

Xiao, X., Liu, Z., Wang, R., Wang, J., Zhang, S., Cai, X., Wu, K., Bergan, R., Xu, L. & Fan, D., 2015, In : Oncotarget. 6, 5, p. 3225-3239 15 p.

Research output: Contribution to journalArticle

Genistein
Colorectal Neoplasms
Neoplasm Metastasis
Vascular Endothelial Growth Factor Receptor-3
Matrix Metalloproteinase 2
14 Citations (Scopus)

Spectral biomarkers for chemoprevention of colonic neoplasia: A placebo-controlled double-blinded trial with aspirin

Roy, H. K., Turzhitsky, V., Wali, R., Radosevich, A. J., Jovanovic, B., Della'Zanna, G., Umar, A., Rubin, D. T., Goldberg, M. J., Bianchi, L., de la Cruz, M., Bogojevic, A., Helenowski, I. B., Rodriguez, L., Chatterton, R., Skripkauskas, S., Page, K., Weber, C. R., Huang, X., Richmond, E. & 2 others, Bergan, R. & Backman, V., Oct 26 2015, (Accepted/In press) In : Gut.

Research output: Contribution to journalArticle

Fractals
Chemoprevention
Aspirin
Biomarkers
Placebos
2014
23 Citations (Scopus)

A randomized phase II presurgical trial of transdermal 4-hydroxytamoxifen gel versus oral tamoxifen in women with ductal carcinoma in Situ of the breast

Lee, O., Page, K., Ivancic, D., Helenowski, I., Parini, V., Sullivan, M. E., Margenthaler, J. A., Chatterton, R. T., Jovanovic, B., Dunn, B. K., Heckman-Stoddard, B. M., Foster, K., Muzzio, M., Shklovskaya, J., Skripkauskas, S., Kulesza, P., Green, D., Hansen, N. M., Bethke, K. P., Jeruss, J. S. & 2 others, Bergan, R. & Khan, S. A., Jul 15 2014, In : Clinical Cancer Research. 20, 14, p. 3672-3682 11 p.

Research output: Contribution to journalArticle

Carcinoma, Intraductal, Noninfiltrating
Tamoxifen
Breast
Gels
Sex Hormone-Binding Globulin
75 Citations (Scopus)

Circulating giant macrophages as a potential biomarker of solid tumors

Adams, D. L., Martin, S. S., Alpaugh, R. K., Charpentier, M., Tsai, S., Bergan, R., Ogden, I. M., Catalona, W., Chumsri, S., Tang, C. M. & Cristofanilli, M., Mar 4 2014, In : Proceedings of the National Academy of Sciences of the United States of America. 111, 9, p. 3514-3519 6 p.

Research output: Contribution to journalArticle

Tumor Biomarkers
Macrophages
Neoplasms
Circulating Neoplastic Cells
Pancreatic Neoplasms
25 Citations (Scopus)

Circulating tumor cells exhibit a biologically aggressive cancer phenotype accompanied by selective resistance to chemotherapy

Pavese, J. M. & Bergan, R., Oct 1 2014, In : Cancer Letters. 352, 2, p. 179-186 8 p.

Research output: Contribution to journalArticle

Circulating Neoplastic Cells
Phenotype
Drug Therapy
Prostatic Neoplasms
Neoplasms
14 Citations (Scopus)

Diminished expression of h2-calponin in prostate cancer cells promotes cell proliferation, migration and the dependence of cell adhesion on substrate stiffness

Moazzem Hossain, M., Wang, X., Bergan, R. & Jin, J. P., 2014, In : FEBS Open Bio. 4, p. 627-636 10 p.

Research output: Contribution to journalArticle

Cell adhesion
Cell proliferation
Cell Adhesion
Cell Movement
Prostatic Neoplasms
43 Citations (Scopus)

Genistein inhibits human prostate cancer cell detachment, invasion, and metastasis

Pavese, J. M., Krishna, S. N. & Bergan, R., Jul 1 2014, In : American Journal of Clinical Nutrition. 100, SUPPL. 1

Research output: Contribution to journalArticle

Genistein
Prostatic Neoplasms
Neoplasm Metastasis
Neoplasms
Phase II Clinical Trials
25 Citations (Scopus)

Heat shock protein 27 regulates human prostate cancer cell motility and metastatic progression

Voll, E. A., Ogden, I. M., Pavese, J. M., Huang, X., Xu, L., Jovanovic, B. D. & Bergan, R., 2014, In : Oncotarget. 5, 9, p. 2648-2663 16 p.

Research output: Contribution to journalArticle

HSP27 Heat-Shock Proteins
Cell Movement
Prostatic Neoplasms
Matrix Metalloproteinase 2
Neoplasms
11 Citations (Scopus)

Improving diversity in cancer research trials: The story of the cancer disparities research network

Simon, M. A., De La Riva, E. E., Bergan, R., Norbeck, C., McKoy, J. M., Kulesza, P., Dong, X., Schink, J. & Fleisher, L., 2014, In : Journal of Cancer Education. 29, 2, p. 366-374 9 p.

Research output: Contribution to journalArticle

Research
Neoplasms
Vulnerable Populations
Medical History Taking
Foster Home Care
18 Citations (Scopus)

Mitogen-activated protein kinase kinase 4 (MAP2K4) promotes human prostate cancer metastasis

Pavese, J. M., Ogden, I. M., Voll, E. A., Huang, X., Xu, L., Jovanovic, B. & Bergan, R., Jul 14 2014, In : PLoS One. 9, 7, e102289.

Research output: Contribution to journalArticle

MAP Kinase Kinase 4
HSP27 Heat-Shock Proteins
mitogen-activated protein kinase kinase
Matrix Metalloproteinase 2
prostatic neoplasms
4 Citations (Scopus)

Therapeutic modulation of prostate cancer metastasis

Krishna, S. N. & Bergan, R., Feb 2014, In : Future Medicinal Chemistry. 6, 2, p. 223-239 17 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Neoplasm Metastasis
Drug Discovery
Therapeutics
Cause of Death
2013
19 Citations (Scopus)

A fluorescence-based thermal shift assay identifies inhibitors of mitogen activated protein kinase kinase 4

Krishna, S. N., Luan, C. H., Mishra, R. K., Xu, L., Scheidt, K. A., Anderson, W. F. & Bergan, R., Dec 5 2013, In : PLoS One. 8, 12, e81504.

Research output: Contribution to journalArticle

MAP Kinase Kinase 4
mitogen-activated protein kinase kinase
prostatic neoplasms
Assays
Prostatic Neoplasms
67 Citations (Scopus)

Androgen receptor-independent function of FoxA1 in prostate cancer metastasis

Jin, H. J., Zhao, J. C., Ogden, I., Bergan, R. & Yu, J., Jun 15 2013, In : Cancer Research. 73, 12, p. 3725-3736 12 p.

Research output: Contribution to journalArticle

Androgen Receptors
Prostatic Neoplasms
Neoplasm Metastasis
Cell Movement
Prostate
16 Citations (Scopus)

An orthotopic murine model of human prostate cancer metastasis.

Pavese, J., Ogden, I. M. & Bergan, R., 2013, In : Journal of visualized experiments : JoVE. 79

Research output: Contribution to journalArticle

Prostatic Neoplasms
Neoplasm Metastasis
Circulating Neoplastic Cells
Tumors
Cardiovascular System
13 Citations (Scopus)

A phase i trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia

Wong, S. J., Campbell, B., Massey, B., Lynch, D. P., Cohen, E. E. W., Blair, E., Selle, R., Shklovskaya, J., Jovanovic, B. D., Skripkauskas, S., Dew, A., Kulesza, P., Parimi, V., Bergan, R. & Szabo, E., Sep 2013, In : Oral Oncology. 49, 9, p. 970-976 7 p.

Research output: Contribution to journalArticle

Oral Leukoplakia
Aminolevulinic Acid
Photochemotherapy
Light
Therapeutics

Crystal structure of a type II dehydroquinate dehydratase-like protein from Bifidobacterium longum

Light, S. H., Krishna, S. N., Bergan, R., Lavie, A. & Anderson, W. F., Mar 2013, In : Journal of Structural and Functional Genomics. 14, 1, p. 25-30 6 p.

Research output: Contribution to journalArticle

Hydro-Lyases
Crystal structure
Proteins
Catalytic Domain
Biosynthetic Pathways
15 Citations (Scopus)

Endoglin-Mediated Suppression of Prostate Cancer Invasion Is Regulated by Activin and Bone Morphogenetic Protein Type II Receptors

Breen, M. J., Moran, D. M., Liu, W., Huang, X., Vary, C. P. H. & Bergan, R., Aug 13 2013, In : PLoS One. 8, 8, e72407.

Research output: Contribution to journalArticle

Type II Bone Morphogenetic Protein Receptors
activins
Activins
bone morphogenetic proteins
prostatic neoplasms
9 Citations (Scopus)

Recruitment strategy cost and impact on minority accrual to a breast cancer prevention trial

Dew, A., Khan, S., Babinski, C., Michel, N., Heffernan, M., Stephan, S., Jordan, N., Jovanovic, B., Carney, P. & Bergan, R., Apr 2013, In : Clinical Trials. 10, 2, p. 292-299 8 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Costs and Cost Analysis
Cost-Benefit Analysis
Postal Service
Health
2012
1 Citation (Scopus)

Soy isoflavones for breast cancer risk reduction - Response

Khan, S. A., Chatterton, R. T. & Bergan, R., Jul 2012, In : Cancer Prevention Research. 5, 7, p. 986-987 2 p.

Research output: Contribution to journalArticle

Isoflavones
Risk Reduction Behavior
Breast Neoplasms
90 Citations (Scopus)

Soy isoflavone supplementation for breast cancer risk reduction: A randomized phase ii trial

Khan, S. A., Chatterton, R. T., Michel, N., Bryk, M., Lee, O., Ivancic, D., Heinz, R., Zalles, C. M., Helenowski, I. B., Jovanovic, B. D., Franke, A. A., Bosland, M. C., Wang, J., Hansen, N. M., Bethke, K. P., Dew, A., Coomes, M. & Bergan, R., Feb 2012, In : Cancer Prevention Research. 5, 2, p. 309-319 11 p.

Research output: Contribution to journalArticle

Isoflavones
Risk Reduction Behavior
Breast Neoplasms
Nipple Aspirate Fluid
Breast
2011
35 Citations (Scopus)

Endoglin regulates cancer-stromal cell interactions in prostate tumors

Romero, D., O'Neill, C., Terzic, A., Contois, L., Young, K., Conley, B. A., Bergan, R., Brooks, P. C. & Vary, C. P. H., May 15 2011, In : Cancer Research. 71, 10, p. 3482-3493 12 p.

Research output: Contribution to journalArticle

Stromal Cells
Cell Communication
Prostate
Neoplasms
Transgenic Mice
28 Citations (Scopus)

Endoglin suppresses human prostate cancer metastasis

Lakshman, M., Huang, X., Ananthanarayanan, V., Jovanovic, B., Liu, Y., Craft, C. S., Romero, D., Vary, C. P. H. & Bergan, R., Jan 2011, In : Clinical and Experimental Metastasis. 28, 1, p. 39-53 15 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Neoplasm Metastasis
Neoplasms
Growth
Endoglin

Erratum: Concise syntheses of the abyssinones and discovery of new inhibitors of prostate cancer and MMP-2 expression (ACS Medicinal Chemistry Letters (2010) 1 (400-405) DOI: 10.1021/ml100110x)

Farmer, R. L., Biddle, M. M., Nibbs, A. E., Huang, X., Xu, L., Bergan, R. & Scheidt, K. A., Mar 10 2011, In : ACS Medicinal Chemistry Letters. 2, 3, p. 257 1 p.

Research output: Contribution to journalArticle

Pharmaceutical Chemistry
Matrix Metalloproteinases
Prostatic Neoplasms
19 Citations (Scopus)

Methyl selenocysteine: Single-dose pharmacokinetics in men

Marshall, J. R., Ip, C., Romano, K., Fetterly, G., Fakih, M., Jovanovic, B., Perloff, M., Crowell, J., Davis, W., French-Christy, R., Dew, A., Coomes, M. & Bergan, R., Nov 2011, In : Cancer Prevention Research. 4, 11, p. 1938-1944 7 p.

Research output: Contribution to journalArticle

Selenium
Pharmacokinetics
Selenomethionine
Neoplasms
Dried Yeast
2 Citations (Scopus)

The Ninth Annual American Association for Cancer Research International Conference on Frontiers in Cancer Prevention Research

Xu, L., Wang, S. S., Healey, M. A., Faupel-Badger, J. M., Wilken, J. A., Battaglia, T., Szabo, E., Mao, J. T. & Bergan, R., Apr 2011, In : Cancer Prevention Research. 4, 4, p. 616-621 6 p.

Research output: Contribution to journalArticle

Research
Neoplasms
Molecular Imaging
Telomere
Insurance Benefits
2010
27 Citations (Scopus)

Concise syntheses of the abyssinones and discovery of new inhibitors of prostate cancer and MMP-2 expression

Farmer, R. L., Biddle, M. M., Nibbs, A. E., Huang, X., Bergan, R. & Scheidt, K. A., Nov 11 2010, In : ACS Medicinal Chemistry Letters. 1, 8, p. 400-405 6 p.

Research output: Contribution to journalArticle

Matrix Metalloproteinase 2
Biological Products
Prostatic Neoplasms
Thiourea
Quinidine
23 Citations (Scopus)

Endoglin phosphorylation by ALK2 contributes to the regulation of prostate cancer cell migration

Romero, D., Terzic, A., Conley, B. A., Craft, C. S., Jovanovic, B., Bergan, R. & Vary, C. P. H., Mar 2010, In : Carcinogenesis. 31, 3, p. 359-366 8 p.

Research output: Contribution to journalArticle

Cell Movement
Prostatic Neoplasms
Phosphorylation
Transforming Growth Factors
Growth Factor Receptors
135 Citations (Scopus)

Inhibition of cancer cell invasion and metastasis by genistein

Pavese, J. M., Farmer, R. L. & Bergan, R., Sep 2010, In : Cancer and Metastasis Reviews. 29, 3, p. 465-482 18 p.

Research output: Contribution to journalArticle

Genistein
Neoplasm Metastasis
Neoplasms
Cyclins
Transforming Growth Factors
2009
67 Citations (Scopus)

Labeling TiO2 nanoparticles with dyes for optical fluorescence microscopy and determination of TiO2-DNA nanoconjugate stability

Thurn, K. T., Paunesku, T., Wu, A., Brown, E. M. B., Lai, B., Vogt, S., Maser, J., Aslam, M., Dravid, V., Bergan, R. & Woloschak, G. E., Jun 5 2009, In : Small. 5, 11, p. 1318-1325 8 p.

Research output: Contribution to journalArticle

Nanoconjugates
Fluorescence microscopy
Fluorescence Microscopy
Nanoparticles
Labeling
62 Citations (Scopus)

MEK4 function, genistein treatment, and invasion of human prostate cancer cells

Xu, L., Ding, Y., Catalona, W. J., Yang, X. J., Anderson, W. F., Jovanovic, B., Wellman, K., Killmer, J., Huang, X., Scheidt, K. A., Montgomery, R. B. & Bergan, R., Aug 2009, In : Journal of the National Cancer Institute. 101, 16, p. 1141-1155 15 p.

Research output: Contribution to journalArticle

Genistein
Prostatic Neoplasms
Matrix Metalloproteinase 2
Prostate
Cell Line
2008
123 Citations (Scopus)

Dietary genistein inhibits metastasis of human prostate cancer in mice

Lakshman, M., Xu, L., Ananthanarayanan, V., Cooper, J., Takimoto, C. H., Helenowski, I., Pelling, J. C. & Bergan, R., Mar 15 2008, In : Cancer Research. 68, 6, p. 2024-2032 9 p.

Research output: Contribution to journalArticle

Genistein
Prostatic Neoplasms
Neoplasm Metastasis
HSP27 Heat-Shock Proteins
Focal Adhesion Protein-Tyrosine Kinases
38 Citations (Scopus)

Gadolinium-conjugated TiO2-DNA oligonucleotide nanoconjugates show prolonged intracellular retention period and T1-weighted contrast enhancement in magnetic resonance images

Paunesku, T., Ke, T., Dharmakumar, R., Mascheri, N., Wu, A., Lai, B., Vogt, S., Maser, J., Thurn, K., Szolc-Kowalska, B., Larson, A., Bergan, R., Omary, R., Li, D., Lu, Z. R. & Woloschak, G. E., Sep 2008, In : Nanomedicine: Nanotechnology, Biology, and Medicine. 4, 3, p. 201-207 7 p.

Research output: Contribution to journalArticle

Nanoconjugates
Oligonucleotides
Gadolinium
Magnetic resonance
DNA
25 Citations (Scopus)

Genistein induces phenotypic reversion of endoglin deficiency in human prostate cancer cells

Craft, C. S., Xu, L., Romero, D., Vary, C. P. H. & Bergan, R., Jan 2008, In : Molecular Pharmacology. 73, 1, p. 235-242 8 p.

Research output: Contribution to journalArticle

Genistein
Activin Receptors
Prostatic Neoplasms
Cell Movement
Phenotype
63 Citations (Scopus)

Inhibition of HIF-1 alpha and VEGF expression by the chemopreventive bioflavonoid apigenin is accompanied by Akt inhibition in human prostate carcinoma PC3-M cells

Mirzoeva, S., Nam, D. K., Chiu, K., Franzen, C. A., Bergan, R. & Pelling, J. C., Sep 2008, In : Molecular Carcinogenesis. 47, 9, p. 686-700 15 p.

Research output: Contribution to journalArticle

Apigenin
Hypoxia-Inducible Factor 1
Flavonoids
Vascular Endothelial Growth Factor A
Prostate
2007
50 Citations (Scopus)

A phase II study of single agent bortezomib in patients with metastatic breast cancer: A single institution experience

Engel, R. H., Brown, J. A., Von Roenn, J. H., O'Regan, R. M., Bergan, R., Badve, S., Rademaker, A. & Gradishar, W. J., Dec 2007, In : Cancer Investigation. 25, 8, p. 733-737 5 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Bortezomib
Proteasome Inhibitors
Multiple Myeloma
Disease-Free Survival
1 Citation (Scopus)

Associations of serum carotenoid levels with serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels in black men and white men

Kim, Y. L., Jacobs, D. R., Gross, M. D., Bergan, R., Gann, P. H., Liu, K. & Gapstur, S. M., Dec 1 2007, In : Cancer Epidemiology Biomarkers and Prevention. 16, 12, p. 2781-2783 3 p.

Research output: Contribution to journalArticle

Insulin-Like Growth Factor Binding Protein 3
Carotenoids
Insulin-Like Growth Factor I
Diet
Serum